Eguchi Katsumi | First Department Of Internal Medicine Nagasaki University Hospital Of Medicine And Dentistry Graduate School Of Biomedical Sciences Nagasaki University

スポンサーリンク

概要

同名の論文著者
First Department Of Internal Medicine Nagasaki University Hospital Of Medicine And Dentistry Graduate School Of Biomedical Sciences Nagasaki Universityの論文著者

関連著者

もっと見る

著作論文

病態形成とアポトーシス (関節リウマチ(第2版)--寛解を目指す治療の新時代) -- (関節リウマチの成因と病態生理)
肺胞出血および急速進行性糸球体腎炎により再燃した顕微鏡的多発血管炎の一例
関節リウマチ (特集膠原病--その入り口から慢性期まで) -- (各論--診断と治療の実際)
5.多発性筋炎/皮膚筋炎に伴う間質性肺炎における気管支肺胞洗浄の検討・当院で経験した27例の検討(第31回日本呼吸器内視鏡学会九州支部総会)
不明熱とTNFレセプター関連周期熱症候群(TRAPS)
高尿酸血症の持続により持続性の多発関節炎を呈した慢性結節性痛風の一例
ANCA関連血管炎の病態と治療における最近の知見
228 不動に伴うラット関節軟骨の形態学的変化,ならびに持続的他動運動の影響(理学療法基礎系,一般演題(ポスター発表演題),第43回日本理学療法学術大会)
診断不明の関節炎を如何に診断するか
Hepatitis C virus kinetics during the first phase of pegylated interferon-alpha-2b with ribavirin therapy in patients with living donor liver transplantation.
Predictive value of suppressor of cytokine signal 3 (SOCS3) in the outcome of interferon therapy in chronic hepatitis C
Interferon-alpha-induced mTOR activation is an anti-hepatitis C virus signal via the phosphatidylinositol 3-kinase-Akt-independent pathway.
シグナル伝達経路を介した alternative splicing の誘導 : その生物学的意義と制御メカニズム
Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population
A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis
サイトカインを標的とする生物学的製剤 TNF阻害薬可溶性TNF受容体IgGキメラ(エタネルセプト) (生物学的製剤の免疫薬理と臨床--変貌する関節リウマチ治療ストラテジー) -- (主要な生物学的製剤の構造,免疫薬理学的特徴と有用性のエビデンス)
A case of cold agglutinin disease in the course of treatment for polymyalgia rheumatica
血管炎症候群 (特集抗TNF-α療法の適応拡大--関節リウマチ以外の疾患治療に向けて)
EVS2-1 早期リウマチの診断 : 現状と将来展望(リウマチ疾患診療の最新情報-特に関節リウマチについて-, 第19回日本アレルギー学会春季臨床大会)
アダリムマブの欧米におけるエビデンス (第1土曜特集関節リウマチのパラダイムシフト--生物学的製剤時代の最新治療動向) -- (生物学的製剤の最新エビデンス)
新しい疾患概念'自己炎症症候群' (特集膠原病--病態解明・新規治療の光明) -- (特論)
臨床症状関節症状 (関節リウマチ(第2版)--寛解を目指す治療の新時代) -- (関節リウマチの検査・診断)
A case of periodic-fever-syndrome-like disorder with lipodystrophy, myositis, and autoimmune abnormalities
卒後研修講座関節リウマチの早期診断と臨床経過の予知
Cutaneous vasculitis induced by TNF inhibitors : a report of three cases
Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics
Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variables
開発メーカーが知っておきたい抗体医薬品(抗リウマチ薬)の有害事象 (特集抗体医薬品の現在進行形--開発・生産技術・特許範囲)
Successful treatment of chronic lupus myocarditis with prednisolone and mizoribine
Long-term efficacy of intravenously administered immunoglobulin in a case of polymyositis with limited application of steroid therapy.
Contribution of an adenine to guanine single nucleotide polymorphism of the matrix metalloproteinase-13 (MMP-13) -77 promoter region to the production of anticyclic citrullinated peptide antibodies in patients with HLA-DRB1^*shared epitope-negative rheuma
Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor
Putative IgG4-related pituitary disease with hypopituitarism and/or diabetes insipidus accompanied with elevated serum levels of IgG4
Emergence of anti-islet autoantibodies in Japanese patients with type 1 diabetes
First Japanese Patient Treated with Parathyroid Hormone Peptide Immunization for Refractory Hypercalcemia Caused by Metastatic Parathyroid Carcinoma
A Long-term Follow-up of Serum Myeloperoxidase Antineutrophil Cytoplasmic Antibodies (MPO-ANCA) in Patients with Graves Disease Treated with Propylthiouracil
In rheumatoid arthritis patients treated with tocilizumab, the rate of clinical disease activity index (CDAI) remission at 24 weeks is superior in those with higher titers of IgM-rheumatoid factor at baseline
Disease activity score 28 may overestimate the remission induction of rheumatoid arthritis patients treated with tocilizumab : comparison with the remission by the clinical disease activity index
Trajectories of anti-islet autoantibodies before development of type 1 diabetes in interferon-treated hepatitis C patients. Case reports and a literature review
Increased incidence of pre-diabetes mellitus at a department of rheumatology : a retrospective study
Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows and excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors
Treatment discontinuation in patients with very early rheumatoid arthritis in sustained simplified disease activity index remission after synthetic disease-modifying anti-rheumatic drug administration
自己炎症症候群
自己炎症疾患の新たな展開 : 内科医でも知っておく必要があります

もっと見る

スポンサーリンク